go back

Brexucabtagene Autoleucel (Tecartus) CAR-T Therapy

Connecticut rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $776,247 · 10th–90th $0$1,479,1080%20%10th90th$776,247Professionalmedian $489,779 · 10th–90th $489,779$588,8440%50%90th$489,779$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$676,082.98
Median
$1,096,478.20
Typical High
$1,479,108.39
Aetna
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$537,031.80
Anthem BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.03
Anthem BCBS
Setting
Professional
Modifier
Global
Typical Low
$489,778.82
Median
$489,778.82
Typical High
$489,778.82
Cigna
Setting
Professional
Modifier
Global
Typical Low
$467,735.14
Median
$489,778.82
Typical High
$588,843.66
ConnectiCare
Setting
Professional
Modifier
Global
Typical Low
$416,869.38
Median
$489,778.82
Typical High
$794,328.23
United
Setting
Professional
Modifier
Global
Typical Low
$363,078.05
Median
$549,540.87
Typical High
$851,138.04